GM2A and Alzheimer disease: The PRM-MS method employed herein has previously been applied to investigate endo-lysosomal dysfunction in AD and PD patients, with the later demonstrating altered CSF concentrations of multiple cathepsins, GM2A and LAMP2 [37].